GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » 5-Year Yield-on-Cost %

Deep Medicine Acquisition (Deep Medicine Acquisition) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition 5-Year Yield-on-Cost %?

Deep Medicine Acquisition's yield on cost for the quarter that ended in Sep. 2023 was 0.00.


The historical rank and industry rank for Deep Medicine Acquisition's 5-Year Yield-on-Cost % or its related term are showing as below:



DMAQ's 5-Year Yield-on-Cost % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 4.115
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Deep Medicine Acquisition's 5-Year Yield-on-Cost %

For the Shell Companies subindustry, Deep Medicine Acquisition's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deep Medicine Acquisition's 5-Year Yield-on-Cost % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's 5-Year Yield-on-Cost % falls into.



Deep Medicine Acquisition 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Deep Medicine Acquisition is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Deep Medicine Acquisition  (NAS:DMAQ) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Deep Medicine Acquisition 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
595 Madison Avenue, 12th Floor, New York, NY, USA, 10017
Website
Deep Medicine Acquisition Corp is a blank check company.
Executives
John Chiang director 3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong director 2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen director, officer: Chief Executive Officer C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo officer: Chief Financial Officer 40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc 10 percent owner 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017

Deep Medicine Acquisition (Deep Medicine Acquisition) Headlines

From GuruFocus

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By GlobeNewswire GlobeNewswire 10-24-2022

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By Value_Insider Value_Insider 10-24-2022